Nazione: Regno Unito
Lingua: inglese
Fonte: MHRA (Medicines & Healthcare Products Regulatory Agency)
Aspirin
DE Pharmaceuticals
N02BA01
Aspirin
300mg
Dispersible tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 04070100
Dispersible Aspirin 300 MG Tablets 16’s ’Pull Out’ leaflet LABEL (Seven Panel) V1 NEW LABEL-Leaflet Layout PLEASE REMOVE THIS CUTTER GUIDE BEFORE PRINTING 16 Tablets Item Code DVL016/6 (to be confirmed) Print Colours Cyan P342 (K) black 100% Patient Information Leaflet for Dispersible Aspirin Tablets 300mg _Read this leaflet carefully before taking these tablets._ _It does not contain all the information about your medicine _ _that you may need to know, so ask your doctor or pharmacist _ _if you have any questions._ _This leaflet only applies to Dispersible Aspirin Tablets 300mg._ 1. WHAT THESE TABLETS DO These tablets contain Aspirin which is a type of painkiller. It is used to relieve pain, swelling and high temperature. It can be used to treat headaches, migraine, neuralgia, toothache, sore throat, period pains and for the relief of sprains, strains, rheumatic pain, sciatica, lumbago, muscle aches, fibrositis, joint swelling and stiffness. 2. CHECK BEFORE YOU TAKE Do not take these tablets if you: • Are allergic to Aspirin, NSAIDs which includes those when in attacks of asthma, angioedema, uticaria or rhinitis have been precipitated by aspirin or any other NSAID or any of the other ingredients listed in section 6 • Have a stomach ulcer or have had problems with ulcers in the past • Suffer from haemophilia or any other bleeding condition • Suffer from gout or had in the past • Are in the last 3 months of pregnancy or are breast feeding. Important warning: Do not give this medicine to children under the age of 16 unless your doctor tells you. This is because there is a possible association between Aspirin and Reye’s Syndrome when given to children. Reye’s syndrome is a very rare disease, which can be fatal. Take special care and tell your doctor if you: • Are intolerant to some sugars as these tablets contain lactose • Have asthma or have ever had it in the past • Have dehydration • Have been told you are deficient in glucose-6-phosphate dehydrogenase Tell your doctor or pharmacist i Leggi il documento completo
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Dispersible Aspirin Tablets 300mg 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 300mg Aspirin 3 PHARMACEUTICAL FORM White uncoated tablets 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Aspirin has analgesic, antipyretic and anti-inflammatory actions. It is indicated for: 1) The relief of headache, toothache, migraine, neuralgia, sore throat, dysmenorrhoea. 2) The symptomatic relief of influenza, feverishness, rheumatic pains, sciatica, lumbago, fibrositis, muscular aches and pains. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION The tablets should be dispersed in water before administration. ADULTS INCLUDING ELDERLY: _ _1-2 tablets at intervals of not less than 4 hours, to a maximum of four doses in 24 hours. CHILDREN: Do not give to children aged under 16 years, unless specifically indicated (e.g. for Kawasaki’s disease). To be dispersed in water for oral use. 4.3 CONTRAINDICATIONS Aspirin should not be taken by patients with the following conditions: • Known hypersensitivity to aspirin, other ingredients in the product, other salicylates or non-steroidal anti-inflammatory drugs (a patient may have developed anaphylaxis, angioedema, asthma, rhinitis or urticaria induced by aspirin or other NSAIDs). • Nasal polyps associated with asthma (high risk of severe sensitivity reactions). • Active, or history of recurrent peptic ulcer, dyspepsia and/or gastric/intestinal haemorrhage, or other kinds of bleeding such as cerebrovascular haemorrhages. • Haemorrhagic diathesis; coagulation disorders such as haemophilia and thrombocytopenia. • Concurrent anticoagulant therapy should be avoided. • Severe hepatic impairment • Severe renal impairment • Severe cardiac failure • Doses >100 mg/day during the third trimester of pregnancy (see section 4.6); • Methotrexate used at doses >15mg/week (see section 4.5). • children under 16 years old, unless specifically indicated (e.g. Kawasaki’s disease). 4.4 SPECIAL WARNINGS AND Leggi il documento completo